Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net

119. Hackam DG, Tan MK, Honos GN, Leiter LA, Langer A, Goodman
SG. How does the prognosis of diabetes compare with that of established
vascular disease? Insights from the Canadian Vascular Protection
(VP) Registry. Am Heart J. 2004;148(6):1028-33.
120. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality
from coronary heart disease in subjects with type 2 diabetes and in
nondiabetic subjects with and without prior myocardial infarction. N
Engl J Med. 1998;339(4):229-34.
121. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et
al. The impact of diabetes mellitus on mortality from all causes and
coronary heart disease in women: 20 years of follow-up. Arch Intern
Med. 2001;161(14):1717-23.
122. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring
JE, et al. Diabetes and all-cause and coronary heart disease mortality
among US male physicians. Arch Intern Med. 2001;161(2):242-7.
123. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The
gender-specific impact of diabetes and myocardial infarction at baseline
and during follow-up on mortality from all causes and coronary
heart disease. J Am Coll Cardiol. 2005;45(9):1413-8.
124. McGin T, Guyatt G. Diagnosis.Clinical prediction Rules. In: American
Medical Association, editor. User’s Guides to the Medical Literature.
A manual for evidence-based clinical practice. 2002.
125. Marrugat J, D’Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas
J, et al. An adaptation of the Framingham coronary heart disease risk
function to European Mediterranean areas. J Epidemiol Community
Health. 2003;57(8):634-8.
126. Marrugat J, Solanas P, D’Agostino R, Sullivan L, Ordovas J, Cordon
F, et al. Estimación del riesgo coronario en Espana mediante la ecuación
de Framingham calibrada. Rev Esp Cardiol. 2003;56(3):253-61.
127. Marrugat J, Subirana I, Comin E, Cabezas C, Vila J, Elosua R, et al.
Validity of an adaptation of the Framingham cardiovascular risk function:
the VERIFICA Study
811. J Epidemiol Community Health. 2007;61(1):40-7.
128. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine:
a model for the risk of coronary heart disease in Type II diabetes
(UKPDS 56). Clin Sci. 2001;101(6):671-9.
140 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS